Free Trial
NASDAQ:APLM

Apollomics (APLM) Stock Price, News & Analysis

Apollomics logo
$6.29 -0.27 (-4.12%)
As of 09:47 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Apollomics Stock (NASDAQ:APLM)

Key Stats

Today's Range
$6.05
$6.50
50-Day Range
$4.63
$7.26
52-Week Range
$4.47
$35.98
Volume
34,939 shs
Average Volume
99,915 shs
Market Capitalization
$6.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Apollomics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
7th Percentile Overall Score

APLM MarketRank™: 

Apollomics scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Apollomics.

  • Price to Book Value per Share Ratio

    Apollomics has a P/B Ratio of 1.45. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.94% of the float of Apollomics has been sold short.
  • Short Interest Ratio / Days to Cover

    Apollomics has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Apollomics has recently decreased by 30.00%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Apollomics does not currently pay a dividend.

  • Dividend Growth

    Apollomics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.94% of the float of Apollomics has been sold short.
  • Short Interest Ratio / Days to Cover

    Apollomics has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Apollomics has recently decreased by 30.00%, indicating that investor sentiment is improving significantly.
  • Search Interest

    1 people have searched for APLM on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Apollomics insiders have not sold or bought any company stock.

  • Percentage Held by Institutions

    Only 19.13% of the stock of Apollomics is held by institutions.

  • Read more about Apollomics' insider trading history.
Receive APLM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apollomics and its competitors with MarketBeat's FREE daily newsletter.

APLM Stock News Headlines

I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
Biotech fails trials for its leukemia drug
See More Headlines

APLM Stock Analysis - Frequently Asked Questions

Apollomics' stock was trading at $9.75 at the start of the year. Since then, APLM shares have decreased by 33.3% and is now trading at $6.5050.

Apollomics's stock reverse split before market open on Monday, November 25th 2024.The 1-100 reverse split was announced on Thursday, November 21st 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, November 22nd 2024. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

Shares of APLM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Apollomics investors own include NVIDIA (NVDA), Cara Therapeutics (CARA), Akebia Therapeutics (AKBA), Avino Silver & Gold Mines (ASM), Canoo (GOEV), MSP Recovery (LIFW) and Tempest Therapeutics (TPST).

Company Calendar

Today
7/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:APLM
Employees
45
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.49 million
Price / Cash Flow
N/A
Book Value
$4.48 per share
Price / Book
1.45

Miscellaneous

Free Float
N/A
Market Cap
$7.16 million
Optionable
Not Optionable
Beta
0.93
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:APLM) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners